Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFirst Tracks Biotherapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$1.00 | $0.81 | -$0.52 |
| Q2 2026 | 6 | -$0.97 | -$0.62 | -$0.79 |
| Q3 2026 | 8 | -$0.91 | -$0.62 | -$0.79 |
First Tracks Biotherapeutics Inc. Earnings Date And Information
First Tracks Biotherapeutics Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. First Tracks Biotherapeutics Inc. has generated $0 earnings per share over the last year ($0 diluted earnings per share) and currently has a price-to-earnings ratio of -6.52. First Tracks Biotherapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
First Tracks Biotherapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 2026 | N/A | -$1.45 | N/A | $22.26 M | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$1.36 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
First Tracks Biotherapeutics Inc. Earnings: FAQ's
The conference call for First Tracks Biotherapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for First Tracks Biotherapeutics Inc.'s latest earnings report can be read online.
First Tracks Biotherapeutics Inc. (:TRAX) has a recorded net income of $-166,087,000.First Tracks Biotherapeutics Inc. has generated $0 earnings per share over the last four quarters.
First Tracks Biotherapeutics Inc. (:TRAX) has a price-to-earnings ratio of -6.52 and price/earnings-to-growth ratio is -0.07.